-- 
Richter, Forest Report Positive Phase III Cariprazine Result

-- B y   A n d r a s   G e r g e l y
-- 
2011-10-05T06:22:19Z

-- http://www.bloomberg.com/news/2011-10-05/richter-forest-report-positive-phase-iii-cariprazine-result.html
Gedeon Richter Nyrt.,  Hungary ’s
biggest drugmaker, and  Forest Laboratories Inc. (FRX)  reported today
“positive” results from a Phase III clinical trial of
cariprazine, an antipsychotic agent.  Data showed that patients with acute manic episodes who
were treated with cariprazine “experienced significant symptom
improvement compared with placebo-treated patients,” the two
companies said in a statement posted on the website of the
Budapest Stock Exchange today.  To contact the reporter on this story:
Andras Gergely in Budapest at 
 agergely@bloomberg.net   To contact the editor responsible for this story:
Gavin Serkin at 
 gserkin@bloomberg.net  